Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Hepatology

• Publication date

  2004-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JHEP.2004.05.009PMID 15336440
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma volume expansion by albumin in cirrhosis. Relation to blood volume distribution, arterial compliance and severity of disease.

  2003cited by this paper
• Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis

  2003cited by this paper
• Hypoxia is an inducer of vasodilator agents in peritoneal macrophages of cirrhotic patients

  2002cited by this paper
• Catalysis of S-nitrosothiols formation by serum albumin: The mechanism and implication in vascular control

  2002cited by this paper
• Albumin as a drug: biological effects of albumin unrelated to oncotic pressure

  2002cited by this paper
• Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club.

  2000cited by this paper
• Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.

  1999influential reference
• Can the clearance of tumor necrosis factor alpha and interleukin 6 be enhanced using an albumin dialysate hemodiafiltration system?

  1999cited by this paper
• The diagnostic and predictive value of ascites nitric oxide levels in patients with spontaneous bacterial peritonitis

  1998cited by this paper
• Tumor necrosis factor and interleukin‐6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortality

  1998influential reference
• Long‐lasting NO overproduction in cirrhotic patients with spontaneous bacterial peritonitis

  1997cited by this paper
• Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis

  1995cited by this paper
• Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis

  1994cited by this paper
• Assessment of the renin-angiotensin system in cirrhotic patients. Comparison between plasma renin activity and direct measurement of immunoreactive renin.

  1992cited by this paper
• Assessment of the renin-angiotensin system in cirrhotic patients. Comparison between plasma renin activity and direct measurement of immunoreactive renin.

  1992cited by this paper
• Negative inotropic effects of cytokines on the heart mediated by nitric oxide.

  1992cited by this paper
• Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

  1992cited by this paper
• American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis

  1992cited by this paper
• Measurement of hepatic blood flow, hepatic extraction and intrinsic clearance of indocyanine green in patients with cirrhosis. Comparison of a non-invasive pharmacokinetic method with measurements using hepatic vein catheterization

  1991cited by this paper
• Optimization of ascitic fluid culture technique.

  1988cited by this paper
• The hepatic coma syndromes and lactulose

  1980cited by this paper
• The hepatic coma syndromes and lactulose: By H. O. Conn and M. M. Lieberthal. 419 pp., $42.00. Williams and Wilkins Company, Baltimore, Maryland

  1979cited by this paper

• From Adults to Children: Rethinking Albumin Therapy in Pediatric Cirrhosis.

  2025cites this paper
• Effect of plasma exchange with albumin replacement on albumin functionality and organ dysfunction in acute-on-chronic liver failure

  2024cites this paper
• HEPATORENAL SYNDROME IN CIRRHOSIS.

  2024cites this paper
• Pharmacological Interventions for Cirrhotic Ascites: From Challenges to Emerging Therapeutic Horizons

  2024cites this paper
• AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review.

  2023cites this paper
• Prise en charge d’une ascite cirrhotique

  2023cites this paper
• Albumin, an interesting and functionally diverse protein, varies from ‘native’ to ‘effective’ (Review)

  2023cites this paper
• A Novel Multi-Component Formulation Reduces Inflammation In Vitro and Clinically Lessens the Symptoms of Chronic Eczematous Skin

  2023cites this paper
• Controversies regarding albumin therapy in cirrhosis

  2023cites this paper
• POSITION STATEMENT ON THE USE OF ALBUMIN IN LIVER CIRRHOSIS.

  2022cites this paper
• Use of human albumin infusion in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials

  2022cites this paper
• Targeted Albumin Infusions Do Not Improve Systemic Inflammation or Cardiovascular Function in Decompensated Cirrhosis

  2022cites this paper
• Peritransplant Renal Dysfunction in Liver Transplant Candidates.

  2022cites this paper
• Albumin for people with liver cirrhosis and bacterial infections

  2021cites this paper
• Albumin Utilization in Spontaneous Bacterial Peritonitis

  2021cites this paper
• Hepatorenal Syndrome.

  2021cites this paper
• Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction.

  2021cites this paper
• Hepatorenal syndrome in acute-on-chronic liver failure with acute kidney injury: more questions requiring discussion

  2021cites this paper
• Critical care considerations in the management of acute-on-chronic liver failure.

  2020cites this paper
• Acute kidney injury: A critical care perspective for orthotopic liver transplantation.

  2020cites this paper
• High expression of a vascular stricture‐related marker is predictive of an early response to tolvaptan, and a low fractional excretion of sodium is predictive of a poor long‐term survival after tolvaptan administration for liver cirrhosis

  2020cites this paper
• Albumin administration in patients with decompensated liver cirrhosis: a meta-analytic update.

  2020cites this paper
• Efficacy and Safety of IV albumin for non-spontaneous bacterial peritonitis infection among patients with cirrhosis: A systematic review and meta-analysis.

  2020cites this paper
• Effects Q1 of Albumin Q2 Treatment Q3 on Systemic and Portal Hemodynamics and Systemic In fl ammation in Patients With Decompensated Cirrhosis

  2019cites this paper
• Albumin in Cirrhosis: More Than a Colloid

  2019cites this paper
• Albumin for cirrhotic patients with extraperitoneal infections: A meta‐analysis

  2019cites this paper
• Acute kidney injury in cirrhosis: implications for liver transplantation

  2019cites this paper
• Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis.

  2019cites this paper
• Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: A literature review

  2018cites this paper
• Alterações funcionais da albumina na cirrose hepática

  2018cites this paper
• Renal Complications in Acute and Chronic Liver Disease

  2018cites this paper
• Treatment of Hyponatremia in End-Stage Liver Disease: New Tools in the Shed

  2018cites this paper
• ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for an interventional randomised controlled trial

  2018cites this paper
• Intensive Care Therapy for Patients with Advanced Liver Diseases

  2018cites this paper
• INTENSIVE CARE MANAGEMENT OF PATIENTS WITH LIVER DISEASE : proceedings of a single-topic conference sponsored by the Brazilian Society of Hepatology

  2017cites this paper
• Role of albumin in cirrhosis: from a hospitalist’s perspective

  2017cites this paper
• Artificial liver support in pigs with acetaminophen-induced acute liver failure

  2017cites this paper
• Prevention of acute kidney injury in Intensive Care Units.

  2017cites this paper
• Role of albumin in diseases associated with severe systemic inflammation: Pathophysiologic and clinical evidence in sepsis and in decompensated cirrhosis.

  2016cites this paper
• Effect of different therapeutic modalities on systemic, renal, and hepatic hemodynamics and short-term outcomes in cirrhotic patients with spontaneous bacterial peritonitis

  2016cites this paper
• Population Based Trends in the Incidence of Hospital Admission for the Diagnosis of Hepatorenal Syndrome: 1998–2011

  2016cites this paper
• ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for a single-arm feasibility trial

  2016cites this paper
• A practical guide to assess the Nancy histological index for UC

  2016cites this paper
• Title : Albumin infusion improves renal blood flow autoregulation in patients with acute decompensation of cirrhosis and acute kidney injury

  2015cites this paper
• Intensive care management of patients with liver disease: proceedings of a single-topic conference sponsored by the Brazilian Society of Hepatology.

  2015cites this paper
• Albumin infusion improves renal blood flow autoregulation in patients with acute decompensation of cirrhosis and acute kidney injury

  2015cites this paper
• Paper Alert

  2015cites this paper
• Recent Advances in Cirrhotic Cardiomyopathy

  2015cites this paper
• Albumin in chronic liver disease: structure, functions and therapeutic implications

  2015cites this paper
• Table 1 Clinical characteristics of patients at diagnosis of spontaneous bacterial peritonitis episodes who did receive (A) and who did not receive (B) albumin

  2015cites this paper
• Renal insufficiency in the patient with chronic liver disease.

  2015cites this paper
• Acute Kidney Injury in Cirrhosis.

  2015cites this paper
• Renal dysfunction in patients with cirrhosis: Where do we stand?

  2014cites this paper
• Review article: advances in the management of patients with cirrhosis and portal hypertension‐related renal dysfunction

  2014cites this paper
• Human serum albumin, systemic inflammation, and cirrhosis.

  2014cites this paper
• Current limits and future challenges in the management of renal dysfunction in patients with cirrhosis: report from the International Club of Ascites

  2013cites this paper
• Albumin: Pathophysiologic basis of its role in the treatment of cirrhosis and its complications

  2013cites this paper
• Reply to: "Effect of albumin on survival in septic cirrhotic patients other than spontaneous bacterial peritonitis. The question remains open".

  2013cites this paper
• Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: molecular mechanisms

  2013cites this paper
• Estudis sobre la insuficiència renal en la cirrosi hepàtica: Anàlisi del pronòstic i investigació en el tractament farmacològic de la síndrome hepatorenal

  2013cites this paper
• Albumin Reduces Paracentesis-Induced Circulatory Dysfunction and Reduces Death and Renal Impairment among Patients with Cirrhosis and Infection: A Systematic Review and Meta-Analysis

  2013cites this paper
• Reply to: ''Effect of albumin on survival in septic cirrhotic patients other than spontaneous bacterial peritonitis. The question remains open''

  2013cites this paper
• Infeções bacterianas no doente com cirrose hepática

  2013cites this paper
• A reproducible, clinically relevant, intensively managed, pig model of acute liver failure for testing of therapies aimed to prolong survival

  2013cites this paper
• Effect of albumin on survival in septic cirrhotic patients other than spontaneous bacterial peritonitis. The question remains open.

  2013cites this paper
• Evaluation of different therapeutic approaches for spontaneous bacterial peritonitis.

  2012cites this paper
• Role of albumin treatment in patients with spontaneous bacterial peritonitis.

  2012cites this paper
• Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study.

  2012cites this paper
• Effect of renal impairment on mortality of patients with cirrhosis and spontaneous bacterial peritonitis.

  2012cites this paper
• Hepatorenal syndrome: a severe, but treatable, cause of kidney failure in cirrhosis.

  2012cites this paper
• [Physiopathological bases for the use of human albumin in liver cirrhosis].

  2012cites this paper
• Abdominal Wall, Umbilicus, Peritoneum, Mesenteries, Omentum, and Retroperitoneum

  2012cites this paper
• Management of End-Stage Liver Disease and the Role of Liver Transplantation in HIV-Infected Patients

  2012cites this paper
• Management of bacterial infections in cirrhosis.

  2012cites this paper
• Medical Progress Renal Failure in Cirrhosis

  2011cites this paper
• Diagnosis of spontaneous bacterial peritonitis in infants and children with chronic liver disease: A cohort study

  2011cites this paper
• Type of Edema in Posterior Reversible Encephalopathy Syndrome Depends on Serum Albumin Levels: An MR Imaging Study in 28 Patients

  2011influential citation
• Care of the liver transplant candidate.

  2011cites this paper
• Should albumin be used in all patients with spontaneous bacterial peritonitis?

  2011influential citation
• Pathophysiological basis of albumin use in cirrhosis.

  2011cites this paper
• Immune dysfunction and infections in patients with cirrhosis.

  2011cites this paper
• Ascites and Spontaneous Bacterial Peritonitis

  2011cites this paper
• Medical management of ascites

  2011cites this paper
• Renal failure in chronic liver disease and the hepatorenal syndrome.

  2011cites this paper
• Terlipressin for Hepatorenal Syndrome: Novel Strategies and Future Perspectives

  2011cites this paper
• Vasoconstrictor Therapy for Hepatorenal Syndrome

  2011cites this paper
• Antibiotic Prophylaxis and Management of Bacterial Infections

  2011cites this paper
• Bacterial infections in patients with liver cirrhosis

  2011cites this paper
• Large-Volume Paracentesis: Which Plasma Expander?

  2011cites this paper
• Albumin: Not Just a Plasma Expander

  2011cites this paper
• Role of Infections in Hepatorenal Syndrome

  2011cites this paper
• Abstract and Introduction

  2011cites this paper
• Renal and circulatory dysfunction in cirrhosis: current management and future perspectives.

  2010cites this paper
• [Intensive care of patients with acute liver failure].

  2010cites this paper
• Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis.

  2010cites this paper
• Optimal management of hepatorenal syndrome in patients with cirrhosis

  2010cites this paper
• Peritoneal dialysis in patients with cirrhosis and ascites.

  2010cites this paper
• Critical care "normality": individualized versus protocolized care.

  2010cites this paper
• Complications of Liver Cirrhosis

  2010cites this paper
• Characterization of peptides and proteins in commercial HSA solutions

  2010cites this paper